From Our 2010 Archives
Medical Marijuana Has Merit, Research Shows
Although Research Shows Medical Mariuana Works, Critics Say California Center's Research Is Flawed
Latest MedicineNet News
Reviewed By Louise Chang, MD
Feb. 18, 2010 -- Marijuana can be a promising treatment for some specific, pain-related medical conditions, according to California researchers who presented an update of their findings Wednesday to the California Legislature and also released them to the public.
"I think the evidence is getting better and better that marijuana, or the constituents of cannabis, are useful at least in the adjunctive treatment of neuropathy," Igor Grant, MD, executive vice-chairman of the department of psychiatry at the University of California San Diego School of Medicine and director of the Center for Medicinal Cannabis Research at the University of California, tells WebMD.
"We don't know if it's a front-line treatment. I'm hoping the results of our studies will prompt larger-scale studies that involve a much more varied population."
"This [report given to the Legislature] sets the stage of larger-scale studies," he says.
Some experts who reviewed the report say some of the studies are flawed and that they worry about the long-term health effects of marijuana smoke.
Perspective: Medical Marijuana Research
Some observers speculated that the researchers presented their report to the Legislature to call attention to marijuana research because an initiative to legalize marijuana for general use is expected to be on the California ballot in November 2010.
But Grant says that's not the case. "We sent it to the Legislature because our report was due," he says.
The program Grant directs was launched in 1999, when the California Legislature passed (and the governor signed) SB 847. Since then, the center has completed five scientific trials, with more in progress.
Medical Marijuana: The Research Scorecard
Five studies, published in peer-reviewed medical journals, show the value of marijuana for pain-related conditions, the researchers say in the report.
A sixth study, as yet unpublished, found marijuana better than placebo cigarettes in reducing the spasticity associated with multiple sclerosis and the pain associated with the spasticity.
Medical Marijuana Research: What's Next?
Grant's researchers will finish two more studies, with results expected by 2011, he says. What happens then, when the initial allocation of nearly $8.7 million, awarded back in 2000, runs out?
"We're going to act as a kind of shell or organizational structure to help investigators apply for funding with the NIH [and others]," he says. Grant says he is expecting no more funding from cash-strapped California.
Although 14 states have legalized medical marijuana, he says, California is the only state that has "stepped up to the plate" to do research.
Medical Marijuana Research: Other Opinions
The California center's studies are flawed, says Joel Hay, PhD, professor of pharmaceutical economics and policy at the University of Southern California, Los Angeles, and a vocal critic of medical marijuana.
"It's not medicine," he says of marijuana. "It would never be approved by the FDA.
"I certainly concede that cannabinoids may have a very valuable medical role," he says. But the danger is in the smoking of marijuana, he says, citing health effects.
Isolating the active ingredient is a better approach, he says, and has actually already been done. "If you want a cannabionoid, it's here," he says, referring to Marinol, available and FDA approved. The active ingredient is THC or tetrahydrocannabinol, the same as found in marijuana.
"Marijuana contains a huge variety of compounds, some of which have not even been thoroughly identified," Hay tells WebMD. The studies, he says, are all short-term, with small groups.
Another flaw, he says, is that it's difficult to have a true placebo when studying marijuana. "People know when they are consuming a psychoactive product," he says.
Another flaw is that patients were allowed to continue on their pain medicine, says Kevin Weissman, PharmD, director of drug information services at Los Angeles County+University of Southern California Medical Center. That may have affected the results.
Grant counters that it was not humane to take patients off pain medicines that were providing any degree of relief.
Like Hay, Weissman says marijuana does have an analgesic effect. But he worries about the long-term effect of marijuana smoke and says research is needed to find a safer delivery system that works, such as vaporization.
SOURCES: Igor Grant, MD, executive vice-chairman, department of psychiatry,
University of California San Diego School of Medicine; director, Center for
Medicinal Cannabis Research, University of California.
- Allergic Skin Disorders
- Bacterial Skin Diseases
- Bites and Infestations
- Diseases of Pigment
- Fungal Skin Diseases
- Medical Anatomy and Illustrations
- Noncancerous, Precancerous & Cancerous Tumors
- Oral Health Conditions
- Papules, Scales, Plaques and Eruptions
- Scalp, Hair and Nails
- Sexually Transmitted Diseases (STDs)
- Vascular, Lymphatic and Systemic Conditions
- Viral Skin Diseases
- Additional Skin Conditions